Tailored interventions based on sputum eosinophils versus clinical symptoms for asthma in children and adults

Cochrane Database of Systematic Reviews

Volumn 2017, Issue 8, 2017, Pages

  Petsky, Helen L ^a   Li, Albert ^b   Chang, Anne B ^c  

^a GRIFFITH UNIVERSITY   (Australia)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^c MENZIES SCHOOL OF HEALTH RESEARCH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; ANTIASTHMATIC AGENT;

ADULT; ASTHMA; CHILD; CLINICAL EFFECTIVENESS; CLINICAL EVALUATION; DISEASE EXACERBATION; DISEASE SEVERITY; EOSINOPHIL COUNT; HOSPITALIZATION; HUMAN; INTERVENTION STUDY; OUTCOME ASSESSMENT; PEAK EXPIRATORY FLOW; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; RISK ASSESSMENT; RISK FACTOR; SENSITIVITY ANALYSIS; SPIROMETRY; SPUTUM ANALYSIS; SYMPTOM; SYSTEMATIC REVIEW; ADOLESCENT; CYTOLOGY; DISEASE COURSE; EOSINOPHIL; LEUKOCYTE COUNT; META ANALYSIS; PATHOLOGY; RANDOMIZED CONTROLLED TRIAL (TOPIC); SPUTUM;

ADOLESCENT; ADRENAL CORTEX HORMONES; ADULT; ANTI-ASTHMATIC AGENTS; ASTHMA; CHILD; DISEASE PROGRESSION; EOSINOPHILS; HUMANS; LEUKOCYTE COUNT; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SPUTUM;

EID: 85028346924     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD005603.pub3     Document Type: Review

References (50)

1. Cao WL, Sun YC, Yao WZ. A study on a therapeutic protocol to improve the control of persistent asthma by monitoring sputum eosinophil counts. Chung-Hua Chieh Ho Ho Hu Hsi Tsa Chih Chinese Journal of Tuberculosis & Respiratory Diseases 2007;30(5):334-8. 3181905
2. Chlumsky J, Striz I, Terl M, Vondracek J. Strategy aimed at reduction of sputum eosinophils decreases exacerbation rate in patients with asthma. Journal of International Medical Research 2006;34(2):129-39. 3181907
3. Fleming L, Wilson N, Regamey N, Bush A. Use of sputum eosinophil counts to guide management in children with severe asthma. Thorax 2012;67(11):1015-6. 3181909
4. Green RH, Brightling CE, McKenna S, Hargadon B, Parker D, Bradding P. Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial. Lancet 2002;360(9347):1715-21. 3181911
5. Chakir J, Loubaki L, Laviolette M, Milot J, Biardel S, Jayaram L, et al. Monitoring sputum eosinophils in mucosal inflammation and remodelling: a pilot study. European Respiratory Journal 2010;35(1):48-53. 3181913
6. D'silva L, Gafni A, Thabane L, Jayaram L, Hussack P, Hargreave F, et al. Cost analysis of monitoring asthma treatment using sputum cell counts. Canadian Respiratory Journal 2008;15(7):370-4. 3181914
7. Jayaram L, Pizzichini MM, Cook RJ, Boulet L-P, Lemière C, Pizzichini E, et al. Determining asthma treatment by monitoring sputum cell counts: effect on exacerbations. European Respiratory Journal 2006;27(3):483-94. 3181915
8. Malerba M, Radaeli A, Olivini A, Ragnoli B, Ricciardolo F, Montuschi P. The combined impact of exhaled nitric oxide and sputum eosinophils monitoring in asthma treatment: A prospective cohort study. Current Pharmaceutical Design 2015;21(32):4752-62. 6615360
9. Aldridge RE, Hancox RJ, Cowant JO, Frampton CM, Town GI, Taylor DR. Eosinophils and eosinophilic cationic protein in induced sputum and blood: effects of budesonide and terbutaline treatment. Annals of Allergy, Asthma & Immunology 2002;89(5):492-7. 3181917
10. Almosawi TA, Al-Zubaidy TS, Howorth PH. Sputum eosinophil markers in monitoring asthmatic patients in United Arab Emirates. Saudi Medical Journal 2008;29(7):1061-4. 3181919
11. Foresi A, Mastropasqua B, Chetta A, D'Ippolito R, Testi R, Olivieri D, et al. Step-down compared to fixed-dose treatment with inhaled fluticasone propionate in asthma. Chest 2005;127(1):117-24. 3181921
12. Gauvreau GM, Watson RM, Postma DS, de Monchy GR, Deschesnes F, Boulet L. Effect of ciclesonide 40 μg and 80 μg on early and late asthmatic reactions, and sputum eosinophils after allergen challenge in patients with mild asthma. Journal of Allergy and Clinical Immunology. 2005; Vol. 115:S210. 3181923
13. Giannini D, Di Franco A, Cianchetti S, Bacci E, Dente FL, Vagaggini B, et al. Analysis of induced sputum before and after withdrawal of treatment with inhaled corticosteroids in asthmatic patients. Clinical and Experimental Allergy 2000;30(12):1777-84. 3181925
14. Gibson PG, Saltos N, Fakes K. Acute anti-inflammatory effects of inhaled budesonide in asthma: A randomized controlled trial. American Journal of Respiratory and Critical Care Medicine 2001;163(1):32-6. 3181927
15. Griese M, Koch M, Latzin P, Beck J. Asthma severity, recommended changes of inhaled therapy and exhaled nitric oxide in children: a prospective, blinded trial. European Journal of Medical Research 2000;5(8):334-40. 3181929
16. Jatakanon A, Kharitonov SA, Lim S, Chung KF, Barnes PJ. The effect of differing dosages of inhaled budesonide on asthmatic airway inflammation assessed by induced sputum. European Respiratory Journal 1997;10(Suppl 25):105s. 3181931
17. Jatakanon A, Lim S, Chung KF, Barnes PJ. An inhaled steroid improves markers of airway inflammation in patients with mild asthma. European Respiratory Journal 1998;12(5):1084-8. 3181933
18. Leigh R, Belda J, Parameswaran K, Hussack P, Efthimiadis A, Pizzichini MM, et al. Symptomatic patients with mild asthma with non-eosinophilic airway inflammation do not benefit from increased inhaled steroid treatment: a randomized controlled trial. American Journal of Respiratory and Critical Care Medicine 2000;161:A188. 3181935
19. Lonnkvist K, Hellman C, Lundahl J, Hallden G, Hedlin G. Eosinophil markers in blood, serum, and urine for monitoring the clinical course in childhood asthma: Impact of budesonide treatment and withdrawal. Journal of Allergy and Clinical Immunology 2001;107(5 Suppl):812-7. 3181937
20. Malerba M, Ragnoli B, Radaeli A, Tantucci C. Usefulness of exhaled nitric oxide and sputum eosinophils in the long-term control of eosinophilic asthma. Chest 2008;134(4):733-9. 3181939
21. McKinlay L, Williamson PA, Short PM, Fardon TC, Lipworth BJ. Proof of concept study to evaluate step-down therapy with inhaled corticosteroid alone or additive therapy on surrogate inflammatory markers in asthma. British Journal of Clinical Pharmacology 2011;71:128-31. 3181941
22. McKinlay L, Jackson CM, Williamson PA, Fardon TC, Burns P, Clearie K. Steroid titration against mannitol in mild to moderate asthma: The stamina community study. Journal of Allergy and Clinical Immunology 2011;127:2 Suppl 1. 3181943
23. Meijer RJ, Postma DS, Kauffman HF, Arends LR, Koeter GH, Kerstjens HA. Accuracy of eosinophils and eosinophil cationic protein to predict steroid improvement in asthma. Clinical and Experimental Allergy 2002;32(7):1096-103. 3181945
24. Nocker RE, Out TA, Weller FR, de Riemer MJ, Jansen HM, van der Zee JS. Induced sputum and bronchoalveolar lavage as tools for evaluating the effects of inhaled corticosteroids in patients with asthma. Journal of Laboratory and Clinical Medicine 2000;136(1):39-49. 3181947
25. Prehn A, Seger RA, Torresani T, Molinari L, Sennhauser FH. Evaluation of a clinical algorithm involving serum eosinophil cationic protein for guiding the anti-inflammatory treatment of bronchial asthma in childhood. Pediatric Allergy and Immunology 2000;11(2):87-94. 3181949
26. Smith AD, Cowan JO, Brassett KP, Herbison GP, Taylor DR. Use of exhaled nitric oxide measurements to guide treatment in chronic asthma. New England Journal of Medicine 2005;352(21):2163-73. 3181951
27. Sosa IP, Nanulescu M. Induced sputum--means for detecting bronchial inflammation in children with atopic bronchial asthma and treatment monitoring [Sputa indusa--metoda de evidentiere a inflamatiei bronsice la copiii cu astm bronsic atopic si de monitorizare a tratamentului]. Pneumologia 2004;53(3):79-84. 3181967
28. Van Rensen ELJ, Evertse CE, van Schadewijk WAA, Zwinderman AH, Sterk PJ. Comparison of changes in exhaled nitric oxide, sputum eosinophils and histamine hyperresponsiveness in patients with mild asthma treated with inhaled steroids. American Journal of Respiratory and Critical Care Medicine 1998;157(3 Suppl):A608. 3181953
29. Wark AB, Gibson PG. Clinical usefulness of inflammatory markers in asthma. American Journal of Respiratory Medicine 2003;2(1):11-9. 3181955
30. Wilson NM, Bridge P, Spanevello A, Silverman M. Induced sputum in children: feasibility, repeatability, and relation of findings to asthma severity. Thorax 2000;55(9):768-74. 3181957
31. Zacharasiewicz A, Wilson N, Lex C, Erin EM, Li AM, Hansel T, et al. Clinical use of noninvasive measurements of airway inflammation in steroid reduction in children. American Journal of Respiratory and Critical Care Medicine 2005;171(10):1077-82. 3181959
32. Zubovic I, Rozmanic V, Ahel V, Banac S. Assessment of treatment by measuring the level of eosinophylic cation protein (ECP) in the serum of children with asthma. Paediatria Croatica 2003;47(3):145-8. 3181961
33. Pinot D, Nieves A, Lorec A, Botturi K, Cavailles A, Breen D, Vervloet D, Magnan A. A treatment regime based on induced sputum eosinophilia does not result in a reduction in exacerbations in refractory severe asthmatics. European Respiratory Society 18th Annual Congress; 2008 Oct 3-7; Berlin. 2008. 3181969
34. Bacci E, Cianchetti S, Carnevali S, Bartoli ML, Dente FL, Di Franco A, et al. Induced sputum is a reproducible method to assess airway inflammation in asthma. Mediators of Inflammation 2002;11(5):293-8.
35. BTS/SIGN. British Thoracic Society/Scottish Intercollegiate Guidelines Network. British Guideline on the Management of Asthma: A national clinical guideline 2016. sign.ac.uk/pdf/SIGN153.pdf (accessed 16 February 2017).
36. Cates C. Visual Rx. Online NNT Calculator. www.nntonline.net/: Dr Christopher Cates, 2008.
37. Douwes J, Gibson P, Pekkanen J, Pearce N. Non-eosinophilic asthma: importance and possible mechanisms. Thorax 2002;57:643-648. [DOI: http://dx.doi.org/10.1136/thorax.57.7.643]
38. Elbourne DR, Altman DG, Higgins JPT, Curtin F, Worthington HV, Vail A. Meta-analyses involving cross-over trials: methodological issues. International Journal of Epidemiology 2002;31(1):140-9.
39. Global Initiative for Asthma. Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention, Global Initiative for Asthma (GINA) 2017. ginasthma.org/2017-gina-report-global-strategy-for-asthma-management-and-prevention/ (accessed 16 February 2017).
40. Green RH, Brightling CE, Woltmann G, Parker D, Wardlow AJ, Pavord ID. Analysis of induced sputum in adults with asthma: identification of subgroup with isolated sputum neutrophilia and poor response to inhaled corticosteroids. Thorax 2002;57(10):875-9.
41. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.
42. Karampitsakos T, Gourgoulianis KI. Asthma-COPD Overlap Syndrome (ACOS): Single disease entity or not? Could exhaled nitric oxide be a useful biomarker for the differentiation of ACOS, asthma and COPD?. Medical Hypotheses 2016;91:20-3. [DOI: 10.1016/j.mehy.2016.04.008]
43. National Asthma Council Australia, Melbourne, 2014. Australian Asthma Handbook, Version 1.0. www.nationalasthma.org.au/handbook (accessed 16 February 2017).
44. Ohnishi H, Maeda H, Nishimura Y, Yokoyama M. Benefits of induced sputum for the evaluation of therapeutic efficacy in patients with bronchial asthma. Kobe Journal of Medical Sciences 1998;44(4):149-61.
45. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
46. Robinson D, Humbert M, Buhl R, Cruz AA, Inoue H, Korom S, et al. Revisiting Type 2-high and Type 2-low airway inflammation in asthma: current knowledge and therapeutic implications. Clinical and Experimental Allergy 2017;47(2):161-75. [DOI: 10.1111/cea.12880]
47. Seys SF. Role of sputum biomarkers in the management of asthma. Current Opinion in Pulmonary Medicine 2017;23(1):34-40. [DOI: 10.1097/MCP.0000000000000345]
48. Wardlaw AJ, Brightling C, Green R, Woltmann G, Pavord I. Eosinophils in asthma and other allergic diseases. British Medical Bulletin 2000;56(4):985-1003.
49. Weiss KB, Sullivan SD. The health economics of asthma and rhinitis. Assessing the economic impact. Journal of Allergy and Clinical Immunology 2001;107(1):3-8.
50. Petsky HL, Kynaston JA, Turner C, Li AM, Cates CJ, Lasserson TJ, Chang AB. Tailored interventions based on sputum eosinophils versus clinical symptoms for asthma in children and adults. Cochrane Database of Systematic Reviews 2007, Issue 2. [DOI: 10.1002/14651858.CD005603.pub2]